TipRanks
Immix Biopharma, Inc. (IMMX)
NASDAQ:IMMX
US Market
IMMX
Immix Biopharma
RESEARCH TOOLSreports

Immix Biopharma (IMMX) Income Statement

216 Followers

Immix Biopharma Income Statement

Last quarter (Q2 2026), Immix Biopharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Immix Biopharma's net income was $-11.56M. See Immix Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 29.96M$ 22.67M$ 16.14M$ 8.22M$ 1.35M
Depreciation and Amortization
$ 364.50K$ 115.39K$ 5.47K$ 2.13K$ 2.47K
EBITDA
$ -29.59M$ -21.54M$ -15.56M$ -8.22M$ -24.20M
Operating Income
$ -29.96M$ -22.67M$ -16.14M$ -8.22M$ -1.35M
Other Income/Expenses
$ 555.53K$ 1.02M$ 572.01K$ -497.00$ -23.03M
Pretax Income
$ -29.40M$ -21.66M$ -15.57M$ -8.22M$ -24.38M
Net Income
$ -29.44M$ -21.61M$ -15.43M$ -8.23M$ -24.38M
Per Share Metrics
Basic EPS
$ -0.89$ -0.76$ -0.89$ -0.59$ -6.64
Diluted EPS
$ -0.89$ -0.76$ -0.89$ -0.59$ -6.64
Weighted Average Shares Outstanding
 32.97M 28.29M 17.34M 13.89M 3.67M
Weighted Average Shares Outstanding (Diluted)
 32.97M 28.29M 17.34M 13.89M 3.67M
Currency in USD

Immix Biopharma Earnings and Revenue History